Switch to: References

Add citations

You must login to add citations.
  1. The Precautionary Principle and the Dilemma Objection.Daniel Steel - 2013 - Ethics, Policy and Environment 16 (3):321-340.
    The dilemma objection charges that ‘weak’ versions of the precautionary principle (PP) are vacuous while ‘strong’ ones are incoherent. I respond that the ‘weak’ versus ‘strong’ distinction is misleading and should be replaced with a contrast between PP as a meta-rule and PP proper. Meta versions of PP require that the decision-making procedures used for environmental policy not be susceptible to paralysis by scientific uncertainty. Such claims are substantive because they often recommend against basing environmental policy decisions on cost–benefit analysis. (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   9 citations  
  • Designing Preclinical Studies in Germline Gene Editing: Scientific and Ethical Aspects.Anders Nordgren - 2019 - Journal of Bioethical Inquiry 16 (4):559-570.
    Human germline gene editing is often debated in hypothetical terms: if it were safe and efficient, on what further conditions would it then be ethically acceptable? This paper takes another course. The key question is: how can scientists reduce uncertainty about safety and efficiency to a level that may justify initiation of first-time clinical trials? The only way to proceed is by well-designed preclinical studies. However, what kinds of investigation should preclinical studies include and what specific conditions should they satisfy (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  • Designing Preclinical Studies in Germline Gene Editing: Scientific and Ethical Aspects.Anders Nordgren - 2019 - Journal of Bioethical Inquiry 16 (4):559-570.
    Human germline gene editing is often debated in hypothetical terms: if it were safe and efficient, on what further conditions would it then be ethically acceptable? This paper takes another course. The key question is: how can scientists reduce uncertainty about safety and efficiency to a level that may justify initiation of first-time clinical trials? The only way to proceed is by well-designed preclinical studies. However, what kinds of investigation should preclinical studies include and what specific conditions should they satisfy (...)
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations